The core of our business is reviewing and challenging scientific and clinical data. We integrate the outcomes of our science-driven analyses with business and strategic analytical elements to generate key insights for our clients. Tasks can range from interrogating the merits of an in vitro cell-based experiment or evaluating the statistical assumptions of an ongoing clinical trial to supporting the development of a holistic R&D portfolio strategy.